LIMONCELLO: medication reviews and transitional care
- Universiteit Radboud UMC Nijmegen
- Promovendus Sjacky Cooijmans
- Promoters Kees Kramer, Patricia van den Bemt
- Co-Promoters Wilma Knol, Noortje van Herwaarden
- Jaar 2019-2025
The aim is to present current and new strategies university hospitals can undertake to contain costs of expensive drugs using a drug life cycle approach.
To explore and implement strategies for optimizing healthcare resource utilization in oncology, with the aim of advancing the (financial) sustainability in oncology care.
Hospital expenditure of expensive drugs increases yearly. In addition, shortages are becoming more common. To assure access to healthcare and treatment in the future, sustainable use of expensive drugs is very important. This research aims to optimize treatment with regard to efficacy and safety, while aiming to reduce drug costs.
Het doel is het effect van farmacokinetische boosting op de farmacokinetiek, effectiviteit en toxiciteit van behandeling met olaparib te onderzoeken.